With a strong clinical-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, for example Retrocyte Screen™ and SECANT®, and innovative mobile therapy approaches, positioning alone as being a key contributor from the biotechnology and immunotherapy arena.Our financial investment management small business generates asset-depend… Read More